Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Arvinas's investors include RA Capital Management, Hillhouse Investment, Connecticut Innovations, Canaan Partners, Adage Capital Management.
Arvinas is headquartered in New Haven, United States.
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Arvinas is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arvinas — Funding & Investors." VCBacked, August 15, 2025, https://www.vcbacked.co/company/arvinas. Accessed September 25, 2026.
VCBacked. (2025). Arvinas — Funding & Investors. Retrieved September 25, 2026, from https://www.vcbacked.co/company/arvinas
{{cite web |title=Arvinas — Funding & Investors |url=https://www.vcbacked.co/company/arvinas |website=VCBacked |access-date=September 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated